168 related articles for article (PubMed ID: 38189941)
21. [Treatment of intoxication with new psychoactive substances and methamphetamine].
Flüchter P; Pajonk FG
Med Monatsschr Pharm; 2015 Mar; 38(3):94-100; quiz 101-2. PubMed ID: 26364395
[TBL] [Abstract][Full Text] [Related]
22. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
23. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project.
Helander A; Bäckberg M; Hultén P; Al-Saffar Y; Beck O
Forensic Sci Int; 2014 Oct; 243():23-9. PubMed ID: 24726531
[TBL] [Abstract][Full Text] [Related]
24. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
Helander A; Bäckberg M; Beck O
PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
[TBL] [Abstract][Full Text] [Related]
25. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
Mohr ALA; Logan BK; Fogarty MF; Krotulski AJ; Papsun DM; Kacinko SL; Huestis MA; Ropero-Miller JD
J Anal Toxicol; 2022 Jul; 46(6):e116-e185. PubMed ID: 35445267
[TBL] [Abstract][Full Text] [Related]
26. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
Soussan C; Kjellgren A
Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
[TBL] [Abstract][Full Text] [Related]
27. Retrospective analysis of new psychoactive substances in blood samples of German drivers suspected of driving under the influence of drugs.
Fels H; Herzog J; Skopp G; Holzer A; Paul LD; Graw M; Musshoff F
Drug Test Anal; 2020 Oct; 12(10):1470-1476. PubMed ID: 32652866
[TBL] [Abstract][Full Text] [Related]
28. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
29. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.
Helander A; Beck O; Bäckberg M
Clin Toxicol (Phila); 2015 Jun; 53(5):446-53. PubMed ID: 25881797
[TBL] [Abstract][Full Text] [Related]
30. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
Schifano F; Papanti GD; Orsolini L; Corkery JM
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
[TBL] [Abstract][Full Text] [Related]
31. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
Zawilska JB; Andrzejczak D
Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
[TBL] [Abstract][Full Text] [Related]
32. Acute, chronic, and post-mortem toxicity: a review focused on three different classes of new psychoactive substances.
Rodrigues CHP; Mariotto LS; Castro JS; Peruquetti PH; Silva-Junior NC; Bruni AT
Forensic Toxicol; 2023 Jul; 41(2):187-212. PubMed ID: 36604359
[TBL] [Abstract][Full Text] [Related]
33. Prodrugs of New Psychoactive Substances (NPS): A New Challenge.
Elliott SP; Holdbrook T; Brandt SD
J Forensic Sci; 2020 May; 65(3):913-920. PubMed ID: 31943218
[TBL] [Abstract][Full Text] [Related]
34. Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States.
Palamar JJ; Barratt MJ; Ferris JA; Winstock AR
Am J Addict; 2016 Aug; 25(5):400-7. PubMed ID: 27419383
[TBL] [Abstract][Full Text] [Related]
35. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.
Chung EY; Cha HJ; Min HK; Yun J
Arch Pharm Res; 2021 Apr; 44(4):402-413. PubMed ID: 33811300
[TBL] [Abstract][Full Text] [Related]
36. Synthetic drugs of abuse.
Tamama K
Adv Clin Chem; 2021; 103():191-214. PubMed ID: 34229850
[TBL] [Abstract][Full Text] [Related]
37. A cross-sectional emergency department survey of novel psychoactive substance prevalence.
Fockele C; Armenian P
Am J Emerg Med; 2017 Oct; 35(10):1580. PubMed ID: 28549581
[No Abstract] [Full Text] [Related]
38. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy.
Papa P; Valli A; Di Tuccio M; Buscaglia E; Brambilla E; Scaravaggi G; Gallo M; Locatelli CA
J Psychoactive Drugs; 2021; 53(3):247-255. PubMed ID: 33470904
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
